Ann Mullally
@mullallylab.bsky.social
Heme Chief at Stanford. Physician Scientist studying myeloid malignancies. Views my own.
Fun times at #Stanford DOM, awesome community! @stanforddeptmed.bsky.social
From launching MGR 2.0 with inspiring guests to celebrating #WomenInMedicine, this past month reminded us that community connection is at the heart of everything we do. Check out #StanDOM's September highlights. 👇
October 15, 2025 at 2:49 AM
Fun times at #Stanford DOM, awesome community! @stanforddeptmed.bsky.social
Our own, Prof. Larry Leung is this month’s #Hematology Breakthroughs speaker! A former #Stanford Division Chief of Hematology, Larry’s lab studies the basic biology of thrombosis/hemostasis.
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
October 13, 2025 at 3:56 PM
Our own, Prof. Larry Leung is this month’s #Hematology Breakthroughs speaker! A former #Stanford Division Chief of Hematology, Larry’s lab studies the basic biology of thrombosis/hemostasis.
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
Reposted by Ann Mullally
If you've been meaning to check out the Night Science Podcast, this is the perfect episode to get started with. Everyone is telling me it's our best one yet!
November 27, 2024 at 10:54 PM
If you've been meaning to check out the Night Science Podcast, this is the perfect episode to get started with. Everyone is telling me it's our best one yet!
Very interesting, congrats! 🎊🎉
🚨 New paper alert!
Sex and smoking bias in the selection of somatic mutations in human bladder
www.nature.com/articles/s41...
by @raquelbmi.bsky.social, @ferriol.bsky.social et al (in collaboration with Rosana Risques lab in @uwmedicine.bsky.social)
Sex and smoking bias in the selection of somatic mutations in human bladder
www.nature.com/articles/s41...
by @raquelbmi.bsky.social, @ferriol.bsky.social et al (in collaboration with Rosana Risques lab in @uwmedicine.bsky.social)
Sex and smoking bias in the selection of somatic mutations in human bladder - Nature
Sex bias and association with smoking history identified in the landscape of driver mutations and clonal expansions in normal human bladder tissue may explain the higher bladder cancer risk in men and smokers.
www.nature.com
October 8, 2025 at 6:27 PM
Very interesting, congrats! 🎊🎉
Reposted by Ann Mullally
Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?!
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
October 7, 2025 at 3:46 PM
Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?!
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
Pretty awesome to have Nobel Laureate, Prof. Jennifer Doudna as our Medical Grand Rounds speaker today! #CRISPR @stanforddeptmed.bsky.social
October 1, 2025 at 7:56 PM
Pretty awesome to have Nobel Laureate, Prof. Jennifer Doudna as our Medical Grand Rounds speaker today! #CRISPR @stanforddeptmed.bsky.social
Reposted by Ann Mullally
A @stanfordmedicine.bsky.social clinical trial, led by #StanDOM's Jason Gotlib, results in FDA approval of a new treatment for a rare, deadly blood cancer. https://stan.md/4mXxtti
September 23, 2025 at 3:43 PM
A @stanfordmedicine.bsky.social clinical trial, led by #StanDOM's Jason Gotlib, results in FDA approval of a new treatment for a rare, deadly blood cancer. https://stan.md/4mXxtti
Enjoyed this interview!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
Geneticist Mary-Claire King has had a remarkable career. She changed how we understand hereditary cancer, helped reunite families after Argentina’s dictatorship, and upended conventional wisdom about our evolutionary origins.
buff.ly/nwsUeYu
buff.ly/nwsUeYu
September 21, 2025 at 11:42 PM
Enjoyed this interview!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
Just add students, a new academic year begins! @stanforduniversity.bsky.social
September 16, 2025 at 4:21 PM
Just add students, a new academic year begins! @stanforduniversity.bsky.social
Reposted by Ann Mullally
Happening today at noon! 👇🏽
Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽
September 11, 2025 at 5:58 PM
Happening today at noon! 👇🏽
Reposted by Ann Mullally
David Baltimore, in his own words (2019).
Sixty Years of Discovery | Annual Reviews
Each of us is a story. Mine is a story of doing science for 60 years, and I am honored to be asked to tell it. Even though this autobiography was written for the Annual Review of Immunology, I have ch...
www.annualreviews.org
September 7, 2025 at 10:05 PM
David Baltimore, in his own words (2019).
Reposted by Ann Mullally
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87
www.nytimes.com
September 7, 2025 at 9:07 PM
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...
Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽
September 3, 2025 at 4:00 PM
Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽
Reposted by Ann Mullally
Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18
September 2, 2025 at 6:39 PM
Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18
Reposted by Ann Mullally
Please check out this thread on our latest paper in
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
Haematopoietic stem cell number is not solely defined by niche availability
Nature - Haematopoietic stem cell numbers are restricted at both systemic and local levels.
rdcu.be
August 28, 2025 at 2:19 AM
Please check out this thread on our latest paper in
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
Reposted by Ann Mullally
Platelets sequester and harbor cell-free tumor DNA, which could enhance our ability to make early, microscopic diagnosis of cancer
@science.org
science.org/doi/10.1126/...
science.org/doi/10.1126/...
@science.org
science.org/doi/10.1126/...
science.org/doi/10.1126/...
August 14, 2025 at 9:39 PM
Platelets sequester and harbor cell-free tumor DNA, which could enhance our ability to make early, microscopic diagnosis of cancer
@science.org
science.org/doi/10.1126/...
science.org/doi/10.1126/...
@science.org
science.org/doi/10.1126/...
science.org/doi/10.1126/...
Rescheduled & happening today at noon! 👇🏽
Looking forward to hearing from Stanford #Hematology clinical investigator, Dr. Jason Gotlib as he recounts his outstanding work in advancing the treatment of #mastocytosis, a chronic blood cancer, using small molecule inhibitors of KIT, all the way to FDA approval!
@stanforddeptmed.bsky.social
@stanforddeptmed.bsky.social
July 9, 2025 at 3:27 PM
Rescheduled & happening today at noon! 👇🏽
Reposted by Ann Mullally
And here it is! Our study in clonal hematopoiesis and Alzheimer’s disease — product of 5 years’ gestation. urldefense.proofpoint.com/v2/url?u=htt...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
urldefense.proofpoint.com
July 2, 2025 at 3:17 PM
And here it is! Our study in clonal hematopoiesis and Alzheimer’s disease — product of 5 years’ gestation. urldefense.proofpoint.com/v2/url?u=htt...
Spectacular jacaranda in bloom on campus! @stanforduniversity.bsky.social
June 23, 2025 at 3:53 PM
Spectacular jacaranda in bloom on campus! @stanforduniversity.bsky.social
Reposted by Ann Mullally
Investing in research, education, and care is key to advancing sickle cell and blood disorders worldwide.
The ASH Foundation makes it happen.
Support the cause: https://bit.ly/4hsCh6v
🎥www.youtube.com/watc...
#WorldSickleCellDiseaseDay #Fight4Hematology #SickleCell #HemeSky
The ASH Foundation makes it happen.
Support the cause: https://bit.ly/4hsCh6v
🎥www.youtube.com/watc...
#WorldSickleCellDiseaseDay #Fight4Hematology #SickleCell #HemeSky
June 20, 2025 at 2:00 PM
Investing in research, education, and care is key to advancing sickle cell and blood disorders worldwide.
The ASH Foundation makes it happen.
Support the cause: https://bit.ly/4hsCh6v
🎥www.youtube.com/watc...
#WorldSickleCellDiseaseDay #Fight4Hematology #SickleCell #HemeSky
The ASH Foundation makes it happen.
Support the cause: https://bit.ly/4hsCh6v
🎥www.youtube.com/watc...
#WorldSickleCellDiseaseDay #Fight4Hematology #SickleCell #HemeSky
Reposted by Ann Mullally
Today is #WorldSickleCellDiseaseDay.
Sickle cell disease affects millions, but too many still face delayed diagnosis and limited access to care. Today, ASH raises awareness and invites you to be part of the progress. 🧵👇
Sickle cell disease affects millions, but too many still face delayed diagnosis and limited access to care. Today, ASH raises awareness and invites you to be part of the progress. 🧵👇
June 19, 2025 at 2:00 PM
Today is #WorldSickleCellDiseaseDay.
Sickle cell disease affects millions, but too many still face delayed diagnosis and limited access to care. Today, ASH raises awareness and invites you to be part of the progress. 🧵👇
Sickle cell disease affects millions, but too many still face delayed diagnosis and limited access to care. Today, ASH raises awareness and invites you to be part of the progress. 🧵👇
Congrats, Ruben! Very well deserved #MPNsm
Honored & humbled to receive #BeutlerPrize along w/#RadekSkoda. Measuring #MPN Symptoms & developing the 4 JAKi = #TEAM of dedicated MPN Patients/Investigators/#PharmaColleagues @harrisoncn1 #SergeVerstovsek @jjkiladjian #Vannuchi @RobynScherber #JoyceNiblack @wakeforestmed
June 18, 2025 at 4:11 PM
Congrats, Ruben! Very well deserved #MPNsm
Congrats to all!
ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏
🔗 https://bit.ly/3G14rIW
#HemeSky #ASHAwards
🔗 https://bit.ly/3G14rIW
#HemeSky #ASHAwards
June 18, 2025 at 4:11 PM
Congrats to all!
Reposted by Ann Mullally
news.abbvie.com/2025-06-16-A... Wow — top line VERONA results are negative — no advantage to AZA + VEN compared to AZA alone for higher-risk #MDSsm. AZA or DAC alone remain the standard for HR-MDS. So disappointing😢 🎗️🩸
AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes
AbbVie (NYSE: ABBV) announced the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine in the treatment of newly diagnosed higher-risk myelodysplastic syndrome...
news.abbvie.com
June 16, 2025 at 10:58 PM
news.abbvie.com/2025-06-16-A... Wow — top line VERONA results are negative — no advantage to AZA + VEN compared to AZA alone for higher-risk #MDSsm. AZA or DAC alone remain the standard for HR-MDS. So disappointing😢 🎗️🩸